Omeros Files Application for FDA Approval of Cataract Surgery Drug

Omeros, a clinical stage biopharmaceutical company, has announced that has submitted a new drug application to the FDA for its OMS302, a drug for use during intraocular lens replacement surgery.

Advertisement
Carrie Pallardy

Omeros also intends to submit a marketing authorization application to the European Medicines Agency.

More Articles on Ophthalmology:
Global Surgical Ophthalmology Market to be Worth $9B by 2017
Valeant to Reduce Workforce by 15% After Bausch +Lomb Buyout
7 Recent Ophthalmologist Moves

Decentralized Pharmacy Procurement Is Costing Health Systems Control and Margin

Recommended Live Webinar on Mar 24, 2026 12:00 PM - 1:00 PM CST

Advertisement

Next Up in Ophthalmology

  • Montana physician practice acquired 

    Southlake, Texas-based Retina Consultants of America has acquired Montana Retina Consultants, according to a Feb. 5 news release.  Bozeman-based Montana…

    By: Patsy Newitt

  • Louisiana ophthalmology practice acquired 

    Vision Innovation Partners acquired Ophthalmic Associates of Alexandria (Va.), according to a Feb. 2 press release. Founded in 2010, Ophthalmic…

    By: Patsy Newitt
Advertisement

Comments are closed.